Medtronic, Inc.

Industry: Medical Equipment Supplies

Fortune Rank: 160

Medtronic, Inc. is a medical technology company engaged in manufacturing and selling device-based medical therapies. The Company's product lines include cardiac rhythm management, vascular, cardiac surgery, neurological & diabetes & spinal and ENT. For the 3M ended 7/29/05, net sales rose 15% to $2.69B. Net income fell 28% to $320.6M. Results reflect strong demand for the Company's defibrillator products, offset by higher overhead costs.

Medtronic, Inc. is a medical technology company that provides lifelong solutions for people with chronic disease. It functions in five operating segments, such as Cardiac Rhythm Management, which supplies medical devices designed to treat a range of heart conditions, such as bradycardia, tachyarrhythmia and heart failure; Spinal, Ear, Nose and Throat (ENT) and Surgical Navigation Technologies, which offers products for the treatment of the conditions, such as spinal disorders and ear, nose and throat disorders; Neurological and Diabetes, which offers products for the treatment of the conditions, such as neurological disorders, diabetes and gastroenterology and urology disorders; Vascular, which offers minimally invasive products for the treatment of the conditions, such as coronary artery disease, peripheral vascular disease and abdominal/thoracic aortic aneurysm (AAA/TAA), and Cardiac Surgery, which offers products for the treatment coronary artery disease and heart valve disorders.

Medtronic, Inc.

Medtronic, Inc. is a Fortune 500 company. In 2010 Medtronic, Inc. was ranked number 160 on the Fortune 500 list, making it the 160th largest company in the United States when judged by revenue.

Medtronic, Inc. achieved revenue of $14,599.00 million in 2010 and earned a profit of $2,169.00 million.

Medtronic, Inc.' rank improves

The company ranking improved in 2010, moving up the Fortune 500 list to 160th compared to 196th in 2009. This was based on its 2009 revenue of $13,515 million (a change of 1 million compared to 2010) and profits of $2,231 million (a change of $0 million compared to 2009).

Another point of view

To many investors, profits are more important than the revenue a company earns. If the Fortune 500 was ranked by profits instead of revenue then Medtronic, Inc. would be ranked 65th rather than 160th due to its profits of $2,169 in 2010.

Medtronic, Inc. Revenue* Profit* Fortune Ranking

* US$ Million

USPages Latest Business News At A Glance Business Shortcuts